Magnesium L-Aspartate Hydrochloride
- Atc Codes:A12CC
- CAS Codes:28184-71-6
- PHARMGKB ID:28184-71-6
Table of contents
- Brand Names
- Drug Combinations
- Chemistry
- Pharmacologic Category
- Mechanism of Action
- Therapeutic Use
- Pregnancy and Lactation Implications
- Contraindications
- Warnings and Precautions
- Adverse Reactions
- Drug Interactions
- Dosage
- Pharmacokinetics and Pharmacodynamics
- Special Considerations
Brand Names
Europe
Austria: Emgecard; Bulgaria: Magnerich; Cyprus: Trofocard; Germany: Magnesiocard; Portugal: Magnesiocard, Metabol-Mg.
North America
USA: Maginex.
Drug combinations
Magnesium L-Aspartate Hydrochloride and Potassium Aspartate
Chemistry
Magnesium-L-Aspartate-Hydrochloride: Mg(C~4~H~5~NO~4~) HCl 3H~2~O. Mw: 245.75. CAS-28184-71-6 (anhydrous).
Pharmacologic Category
Replacement Preparations; Electrolyte Solutions. Oral Electrolyte Supplement. Nutritional Supplements. Magnesium Salt. (ATC-Code: A12CC).
Mechanism of action
Cofactor in protein synthesis and carbohydrate metabolism. Important actions on lipoprotein lipase in reducing serum cholesterol and on sodium/potassium ATPase in promoting polarization (e.g. neuromuscular functioning).
Therapeutic use
Dietary supplement.
Pregnancy and lactiation implications
Magnesium crosses placenta and is found in breast milk.
Unlabeled use
Contraindications
Hypersensitivity to any component of the formulation.
Warnings and precautions
For occasional use only. Serious side-effects might occur with prolonged use. Use with extreme caution in myasthenia gravis or other neuromuscular disease. Use with caution in impaired renal function, hepatitis or Addison’s disease (accumulation of magnesium may lead to magnesium intoxication).